Effect of cytosine-Ag


Journal

Dalton transactions (Cambridge, England : 2003)
ISSN: 1477-9234
Titre abrégé: Dalton Trans
Pays: England
ID NLM: 101176026

Informations de publication

Date de publication:
08 Jun 2021
Historique:
pubmed: 12 5 2021
medline: 12 5 2021
entrez: 11 5 2021
Statut: ppublish

Résumé

The redox properties of metallo-base pairs remain to be elucidated. Herein, we report the detailed 1H/13C/109Ag NMR spectroscopic and cyclic voltammetric characterisation of the [Ag(cytidine)2]+ complex as isolated cytosine-Ag+-cytosine (C-Ag+-C) base pairs. We also performed comparative studies between cytidine/Ag+ and other nucleoside/Ag+ systems by using cyclic voltammetry measurements. In addition, to evaluate the effect of [Ag(cytidine)2]+ formation on the chemical reduction of Ag+ to Ag, we utilised the redox reaction between Ag+ and tetrathiafulvalene (TTF). We found that Ag+-mediated base pairing lowers the redox potential of the Ag+/Ag couple. In addition, C-Ag+-C base pairing makes it more difficult to reduce captured Ag+ ions than in other nucleoside/Ag+ systems. Remarkably, the cytidine/Ag+ system can be utilised to control the redox potential of the Ag+/Ag couple in DMSO. This feature of the cytidine/Ag+ system may be exploited for Ag nanoparticle synthesis by using the redox reaction between Ag+ and TTF.

Identifiants

pubmed: 33973617
doi: 10.1039/d1dt00975c
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7633-7639

Auteurs

Takenori Dairaku (T)

School of Pharmaceutical Sciences, Ohu University, 31-1 Misumido, Tomita-machi, Koriyama, Fukushima 963-8611, Japan. t-dairaku@pha.ohu-u.ac.jp y-kashiwagi@pha.ohu-u.ac.jp.

Rika Kawai (R)

School of Pharmaceutical Sciences, Ohu University, 31-1 Misumido, Tomita-machi, Koriyama, Fukushima 963-8611, Japan. t-dairaku@pha.ohu-u.ac.jp y-kashiwagi@pha.ohu-u.ac.jp.

Teppei Kanaba (T)

Application, Bruker Japan K.K., 3-9 Moriya-cho, Kanagawa-ku, Yokohama, Kanagawa 221-0022, Japan.

Tetsuya Ono (T)

School of Pharmaceutical Sciences, Ohu University, 31-1 Misumido, Tomita-machi, Koriyama, Fukushima 963-8611, Japan. t-dairaku@pha.ohu-u.ac.jp y-kashiwagi@pha.ohu-u.ac.jp.

Kentaro Yoshida (K)

School of Pharmaceutical Sciences, Ohu University, 31-1 Misumido, Tomita-machi, Koriyama, Fukushima 963-8611, Japan. t-dairaku@pha.ohu-u.ac.jp y-kashiwagi@pha.ohu-u.ac.jp.

Hajime Sato (H)

Application, Bruker Japan K.K., 3-9 Moriya-cho, Kanagawa-ku, Yokohama, Kanagawa 221-0022, Japan.

Kanako Nozawa-Kumada (K)

Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aza-Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan.

Yoshinori Kondo (Y)

Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aza-Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan.

Jiro Kondo (J)

Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo 102-8554, Japan.

Akira Ono (A)

Department of Material & Life Chemistry, Faculty of Engineering, Kangawa University, 3-27-1 Rokkakubashi, Kanagawa-ku, Yokohama, Kanagawa 221-8686, Japan.

Yoshiyuki Tanaka (Y)

Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan. tanakay@ph.bunri-u.ac.jp.

Yoshitomo Kashiwagi (Y)

School of Pharmaceutical Sciences, Ohu University, 31-1 Misumido, Tomita-machi, Koriyama, Fukushima 963-8611, Japan. t-dairaku@pha.ohu-u.ac.jp y-kashiwagi@pha.ohu-u.ac.jp.

Classifications MeSH